Whether you're looking develop a monoclonal antibody, a multi-specific, or other protein-based therapeutics, we have you covered and can help you optimize your molecule for drug-like properties and deliver development candidates
VARIABLE DOMAIN ENGINEERING
HUMANIZATION
CDR ULTRA-HUMANIZATION
- Paratope mapping
- ABS germlining
LIABILITY ENGINEERING
- Developability
- PTMs
- Hydrophobicity
- Charge patches
- Polyspecificity
- Immunogenicity
Fc ENGINEERING
EFFECTOR FUNCTION
- ADCC, ADCP, CDC
- Effector function null
- FcγR, C1q silent
- Isotype reformating
- Mutations
- Aglycosylation
- Effector function enhanced
- Mutations
- Afucosylation
- Effector function optimized
- Act. vs inhib. FcγRs
HALF-LIFE EXTENSION / OPTIMIZATION
- YTE, CS mutations
- FcRn silencing mutations
FORMATS
MONOCLONAL ANTIBODIES
BI/MULTI-SPECIFICS
T/NK CELL ENGAGERS
NANOBODIES, VHHs
scFvs, CARs
ADCs
OTHER PROTEIN BASED THERAPEUTICS
BIOLOGICAL FUNCTION
ANTAGONISTS
AGONISTS
CELL DEPLETING
PAYLOAD DELIVERY
DEGRADERS
RADIOLIGANDS
PROTEIN REPLACEMENT